Anna Blakney
@AnnaBlakney
👩🏼🔬: Assistant Prof @UBC @UBCMSL @SBME_UBC, part of the RNAissance 🏔: Outdoor enthusiast.
ID:1104229062
http://annablakney.com 19-01-2013 17:39:21
713 Tweets
3,0K Followers
657 Following
ADDR Open Access: Clinical Perspective on Topical Vaccination Strategies.
By Anna K. Blakney & coworkers UBC School of Biomedical Engineering Anna Blakney
#vaccine #TopicalDelivery #perspective
doi.org/10.1016/j.addr…
ICYMI “What this means for us is it requires a much lower dose than a normal messenger RNA vaccine. Scaling this up is really advantageous because you’re able to get 100X as many vaccines from the same batch size.” research2reality.com/health-medicin… UBC School of Biomedical Engineering University of British Columbia University of British ColumbiaNews UBC Engineering
The results are in and Vancouver researchers have racked up 85 awards for March, making it back-to-back months with 85 awardees! This month we're highlighting a new Canada Research Chair: Dr. Anna Blakney at UBC School of Biomedical Engineering.
🔎 March 2024 Awardee List: bit.ly/4aDgMg3
ICYMI The pandemic thrust mRNA vaccines into the spotlight; now, researchers are exploring how to make them faster, cheaper and more powerful. research2reality.com/health-medicin… UBC School of Biomedical Engineering University of British Columbia University of British ColumbiaNews UBC Engineering
So proud of the Canadian Society for Immunology (CSI) and the EDI Committee for letting us examine our historical data and analyze our successes and remaining challenges in EDI: Truly a model for how societies can move the cause forward by being data-driven and open. Kudos to all!
ADDR open access: Clinical Perspective on Topical Vaccination Strategies.
By Anna K. Blakney & coworkers UBC School of Biomedical Engineering
#vaccine #topical #adjuvant #permeation
doi.org/10.1016/j.addr…
Check out our new review on topical vaccination strategies led by Petya Mu Ting and Suiyang | 廖穗杨 with Manish Sadarangani! Why aren't we administering more vaccines via our immune cell-rich skin?! sciencedirect.com/science/articl…
We’re honored to be named one of #Cantor 's exciting private biotechs and to be featured in their Private Company Showcase Series 'Taking mRNA to the Next Level', where we will be discussing our #srRNA platform & its potential across #infectiousdisease , #oncology & #immunology .
I recently spoke with BioInsights on the future of lipid nanoparticles for gene delivery. I give an overview of the opportunities that Azane Therapeutics is exploring using ionizable lipids developed Biomedical Engineering @ University of Toronto OFK Lab.
Link: insights.bio/nucleic-acid-i…
Five Canada Research Chairs have been appointed from UBC Science with foci spanning from gene therapy to air pollution and beyond.
Congratulations Drs. Anna Blakney, Amanda Giang, Katherine Ryan, Carolina Tropini (@CTropini), and Anotida Madzvamuse!
🧐: bit.ly/3IDLxWj
What an honor! Grateful to be a Tier II CRC in Nucleic Acid Bioengineering. And congratulations Carolina Tropini, PhD!
Congratulations to the @UBCMedicine scientists recently named new Canada Research Chairs! 🌟
med.ubc.ca/news/four-ubc-…
CFI / FCI SSHRC NSERC / CRSNG TIPS_SPIIE CIHR UBC School of Biomedical Engineering UBC Department of Psychiatry UBC Pathology
In honour of International Women's Day, we are thrilled to feature some of the amazing women in the School of Biomedical Engineering who are transforming health for everyone. bme.ubc.ca/celebrating-in…
Carolina Tropini, PhD Anna Blakney Nika Shakiba
💬 'Nous n'avons pas besoin d'un grand centre de vaccination pour l'ARN, ce qui ouvre des possibilités de réflexion sur de nouveaux modèles de santé.'
🗣️ Anna Blakney, chercheuse et professeure à l’University of British Columbia
➡️ Le Point #ParisSaclaySummit #ChooseScience #ARN #VaccinsARN #Cancer